Skip to main content

Table 3 Impact of adalimumab dose and screening on tuberculosis rates

From: Does safety make a difference in selecting the right TNF antagonist?

Trial phase Intensity of dosea Screening by chest X-ray Patients tested Tuberculosis cases
I ×20 No 198 5
II ×4 No 284 3
III ×2 Yes 511 0
  1. aNumber of times above the commonly administered dose of 40 mg every 2 weeks. Data on file, Abbott Laboratories, Abbott Park, IL, USA.